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0883-9441/© 2019 Published by Elsevier Inc.a b s t r a c ta r t i c l e i n f oAvailable online xxxx Sepsis is a deadly condition inwhich the outcome is associated with prompt and adequate recognition, intensive
supportive care, antibiotic administration and source control. This last item makes abdominal sepsis a unique
treatment challenge. Although pneumonia constitutes the leading cause of sepsis, abdominal sepsis has unique
features that merit discussion. The abdomen may be implicated as the primary occult, secondary dependent or
secondary independent source of infection. Themajor factors determining whether a patient will develop an un-
complicated infection or septic shock are: (1) patient susceptibility to infections, (2) age, and (3) comorbidities.
The epidemiology of abdominal sepsis and its outcomes are difﬁcult to assess due to the large clinical heteroge-
neity associated with this entity. Further complicating issues is the debate surrounding the effect of early source
control (i.e. the “surgeon effect”). This review evaluates and summarizes the current approach to current chal-
lenges in patient care and which are the future research directions.
© 2019 Published by Elsevier Inc.1. Introduction
Sepsis is a silent killer [1]. It is unpredictable, rapid and often undiag-
nosed due to its non-speciﬁc signs and symptoms [2]. Apart from
prompt recognition, survival from sepsis is associated with adequate
source control and initiation of treatment with antibiotics [3]. The
most common locations of the primary infection include the lungs, uri-
nary tract, skin, and abdominal organs [4]. Although pneumonia consti-
tutes the leading cause of sepsis, abdominal sepsis has unique features
that merit discussion [5].
The abdomen may be implicated as the primary occult, secondary-
dependent or secondary-independent source of sepsis [6]. Examples ofe Care Research Organization
, Dublin 8, Ireland.
-Loeches).each condition are displayed in Table 1. The major factors determining
whether a patient will develop an uncomplicated infection or septic
shock are: patient susceptibility to infections, age and comorbidities [7].
Sepsis is caused by a dysregulated host response to infection [2]. Al-
though sepsis is a systemic process, the pathophysiological response
differs between organs [8]. Initially, the inﬂammatory response is com-
partmentalized in the peritoneal cavity [9]. With disease evolution and
progression to more severe and uncontrolled forms of sepsis such as
septic shock and multi-organ failure, the response becomes systemic
and mortality increases.
Abdominal sepsis is often polymicrobial [10,11]. Gram positive and
negative bacteria share a common mechanism, which allows them to
crosslink, and bind to human vascular endothelial cells. This process
causes dysregulation of normal endothelial haemostasis, characterised
by a loss of cell barrier integrity, apoptosis, sustained release of inﬂam-
matory cytokines and thrombus formation [12,13]. In abdominal sepsis,
Table 1
Conditions and deﬁnitions associated to source of sepsis in critically ill patients.
Conditions Deﬁnitions Example
• Primary occult • In-apparent source of the prob-
lem where the abdomen is
implicated as the primary source
• Cholecystitis (calculous
or acalculous)
• Pancreatitis
• Typhlitis
• Diverticulitis & Appen-
dicitis
• Retroperitoneal
abscess
• Bowel ischemia with
faecal peritonitis
• Secondary
dependent
• When the initial process began
in the abdomen
• Post operative abscess
• Anastomotic leak
• Secondary
independent
source of
sepsis
• When intra-abdominal organ
sustain an insult from splanchnic
hypoperfusion
• Intestinal ischemia
resulting from splanch-
nic hypoperfusion
Fig. 1. Approach to source control management.
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ered as a mechanism of injury (i.e. increased vascular permeability).
Thismechanism iswidely recognized and accepted in the lungs and kid-
neys,where it is classiﬁed as acute lung and kidney injury. A similar pro-
cess occurs in the gut, although this concept is much slower to seep
through. However, the role of the gut as themotor of organ dysfunction
syndrome cannot be denied and difﬁculties in assessing gut function
should not deter us from recognizing its driving role in the multiple
organ failure [14].
The epidemiology of abdominal sepsis and its outcomes are difﬁcult
to assess due to the large clinical heterogeneity associated with this en-
tity. Further complicating issues is the debate surrounding the effect of
early source control (i.e. the “surgeon effect”). A recent randomized clin-
ical trial (RCT) considered complicated intra-abdominal infections
(cIAIs) in patients with mortality ranging from 2% to 3% whilst septic
shock mortality rates in intensive care unit (ICU) patients can be as
high as 50% [15,16].
This narrative review aims to focus in ﬁve topics of current contro-
versy in abdominal sepsis with a focus on critically care patients. Our
aim is to evaluate and summarize the current approach to common
challenges in patient care and which are the future research directions.2. Short-courses of antibiotics in patients with cIAIs
2.1. Background
CIAIs are a heterogeneous group of infections with a highly vari-
able prognosis. The mainstay of treatment, at least for secondary
peritonitis, is source control. This usually requires drainage of dis-
crete collections and correction of the anatomic defect responsible
for on-going contamination. In most cases this can be accomplished
using percutaneous techniques. However, decisions regarding the
type of intervention required hinges on understanding the surgical
options and their risks, which requires close collaboration with a
surgeon (Fig. 1).
Antibiotic therapy is an adjuvant to source control. Based on good
quality evidence [17], the revised guidelines on management of cIAIs
[6] recommend that antibiotic therapy be administered for an uninter-
rupted period of 4-7 days. The daily bedside conﬂict consists of the de-
sire to eradicate the infectious process vs. the collective imperative to
reduce antibiotic exposure in order to prevent emergence of
multidrug-resistant bacteria. Unfortunately, existing guidelines have
failed to show the relevance of existing RCTs for critically ill patients
[18].2.2. Literature review
The STOP-IT trial enrolled 518 patients with cIAIs and adequate
source control to receive antibiotics either until 2 days after the resolu-
tion of fever, leukocytosis, and ileus, with amaximumof 10 days of ther-
apy (control group), or a ﬁxed course of antibiotics (experimental
group) for 4 ± 1 calendar days [17]. The crude mortality was around
1%. The primary outcome (a composite score including surgical site in-
fection, recurrent cIAI, or death) was similar in both groups (22.3% vs.
21.8%, p = .92). The period of exposure to antibiotics was reduced in
the experimental group. While interesting, it remains uncertain
whether these results may be extrapolated to critically ill patients. An-
cillary studies have focused on patients with sepsis, patients at risk of
complications, patients older than 64 years, and patients in whom En-
terococcus and Candida were isolated [16,19-21]. These studies suggest
that a 4-day course can be used in those subpopulations. However,
whether these patients were truly critically ill is unclear; the features
of the populations described in these studies suggest that only few crit-
ically ill patients were included.
Contrary to these studiesMontravers et al. focused speciﬁcally on ICU
patients receiving appropriate empirical antibiotics and an adequate
source control procedure [22]. Among 410 eligible patients, 120 and
116 patients were randomized to 8-days or 15-days of antibiotic ther-
apy, respectively. Eight days of treatment yielded a greater number of
antibiotic free-days (theprimary outcome)and similar 45-daymortality
to 15 days of treatment, although the study was not powered for this
secondary outcome. However, higher rates of percutaneous drainage
and bacteraemia were observed with 8 days of treatment and the rate
of multidrug-resistant bacteria emergence was similar in both groups.
2.3. Recommendations
If source control is readily achieved, short courses of antibiotics are
acceptable since the focus of bacterial dissemination has been elimi-
nated. The standard of care for most patients should probably be
4–5 days of antibiotic therapy. In a selected group of patients (i.e. fol-
lowing drainage of cholangitis), 24 h of antibiotic therapy may be sug-
gested. Prolonging antibiotic treatment should never be an alternative
to source control. Ongoing organ dysfunction despite appropriate ther-
apy should prompt a search for a correctable cause. A computed tomog-
raphy (CT) scan is the best tool for investigation as itmay offer insight to
the optimal treatment approach. Extending antibiotic therapy beyond
5–7 days is reasonable when despite optimal efforts, source control re-
mains inadequate or uncertain.
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A comparison of a ﬁxed to an individually tailored approach (based
on daily clinical assessment and CT scan examination) duration of anti-
biotic therapy would provide important insight into the best mode of
care.
3. Abdominal closure in abdominal sepsis
3.1. Background
Open abdomen treatment (OAT) refers to the action to leave the ab-
domen open post-surgery [23]. The precise impact of OAT in critically ill
patients remains unstudied. Therefore caution should be always
exercised with regards to this invasive intervention [24]. OAT was ini-
tially described for patients with severe abdominal trauma in the con-
text of damage control surgery but has since been extrapolated to
patientswith cIAIs unrelated to trauma. In patientswith CIAI anOAT ap-
proach may be required in several circumstances. These include
1) Rapid patient deterioration with severe physiological compromise
(i.e. the need to shorten the length of surgery), 2) Multiple re-
explorations due to ongoing infection, 3) A high likelihood of abdominal
compartment syndrome and 4) An increased risk of dehiscence due to
severe infection (i.e. the need to defer intestinal anastomosis to the
post-resuscitation period). Although OAT may be lifesaving, it remains
a clinical challenge because of its association with signiﬁcant complica-
tions [25].
The goal of OAT in patients with cIAIs is early source control. The ini-
tial surgical intervention should therefore be kept as simple and brief as
possible. After source control, the patient should be admitted immedi-
ately to the ICU for physiologic optimization. Once physiological balance
has been achieved, the patient may be returned to the operating room
for a deﬁnitive operation. This usually occurs within 24–48 h. Re-
exploration and deﬁnitive surgery should ideally be accompanied by
deﬁnitive closure of the abdomen as this constitutes the basis for
preventing or reducing complications [26]. In a 2014 meta-analysis,
Chen et al. showed clinical advantages of early fascial closure over de-
layed approach in treatment of patients with open abdomen [27].
3.2. Literature review
The literature suggests there is a bimodal distribution of primary clo-
sure rates, with early closure within 7 days and delayed closure after
7 days. These are mostly determined by the technique used for tempo-
rary abdominal closure [28]. Primary closure of the fascia can be
achieved in many cases within days of the initial operation without
technical difﬁculties. Although patients with abdominal sepsis are less
likely to undergo early fascia closure [29], this should be attempted as
soon as sepsis is controlled [27] in order to reduce complications.
Themost serious local complication in patients with OAT is develop-
ment of an entero-atmospheric ﬁstula. The exposed bowel is at risk of
ﬁstulization especially in patients with longstanding OAT. Spontaneous
closure of such ﬁstulae is very rare as the overlying tissue is poorly
vascularized [30]. Delayed fascial closure is deﬁned as fascial abdominal
closure 7 or more days after the opening of the abdomen. Delayed facial
closure is best achieved by progressively and incrementally approxi-
mating the edges of the fascia edges until the abdominal wall defect
has been completely closed.
Temporary abdominal closure should optimally protect the abdom-
inal contents, prevent evisceration, allow removal of infected or toxic
ﬂuid from the peritoneal cavity and prevent formation of ﬁstulas. It
should also avoid damage to the fascia, preserve the abdominal wall do-
main, make re-operation easy and safe and facilitate deﬁnitive closure.
Negative pressure wound therapy techniques are now extensively
used for temporary abdominal closure. This method actively exhibits
species selectivity, suppressing the proliferation of nonfermentinggram-negative bacilli [31], allowing fascial and abdominal wall closure
[32]. Occasionally, abdominal closure cannot be achieved. Such cases
are prone to late development of large abdominal hernias, which may
require complex surgical repair [33].
3.3. Recommendations
OAT may be lifesaving but its association with signiﬁcant morbidity
poses unique clinical challenges. Current guidelines suggest avoiding
routine OAT for patients with cIAIs, but this approach is a pertinent clin-
ical option in a select group of patients with severe physiologically de-
rangement and ongoing infection [6]. In addition, intraabdominal
pressure (IAP) should be continued during OAT as it can guide closure.
It should be realised that patients with OAT can still develop ACS; IAP
can reliably be measured when a vacuum assisted closure (VAC) dress-
ing is applied. It is not advocated to primarily close abdomen when
there is still grade 2 or higher intrabdominal hypertension (IAH). An in-
tegral approach should be also taken into account with an optimal ﬂuid
management to optimize “peritoneal resuscitation” on one hand and in
order to avoid developing acute bowel injury and acute intestinal dis-
tress syndrome on the other [34-36]. Adequate nutrition support is crit-
ical in themanagement of patients with an open abdomen [37]. Several
formulas can be used but as a general rule, an estimate of 2 g of nitrogen
per litre of abdominal ﬂuid output has been proposed/suggested when
calculating the nitrogen balance of any patient with an open abdomen
[38]. There are several important surgical considerations, such as
avoiding exposed feeding tubes, use of permanent meshes in the ab-
dominal wall. If necessary, the use of a non-adherent visceral layer
might be preferable [39].
If a decision has been made to manage the patient with an OAT, re-
ducing the rate of associated complications by early primary closure of
the fascia is recommended once the source of sepsis has been con-
trolled. Negative pressurewound therapy should be considered for tem-
porary abdominal wall closure as it offers several advantages. It is clear
that when opening the abdomen and leaving it open one should think
immediately about when to close [40]. “If you fail to plan, you plan to
fail” accurately summarizes the main goal in this situation: begin plan-
ning closure as soon as the abdomen is opened [41].
3.4. Future research agenda step
Although strong evidence is lacking, there is a clinical feeling that in
some cases with cIAI opening the abdomen may promote resolution of
the infectious process. Retrospective studies report on use of OAT in pa-
tients with cIAIs. However, only one study reported randomization of
patients to a closed or open strategy in recent years [42]. Using a sand-
wich technique with non-absorbable mesh sutured to the fascia per-
formed the temporary abdominal closure. This study was stopped at
the ﬁrst interim analysis because the risk of death was higher in the
OAT group although not reaching statistical signiﬁcance. Another
study [43] is now planned to address this question in the most severe
patients (NCT03163095).
Because in cIAIs several laparotomies may be required, two types of
well-designed studies comparing two approaches are required in this
population: 1) OATwith temporary abdominal closure compared to pri-
mary abdominal closure with on-demand laparotomy; 2) Primarily clo-
sure of the fascia vs. leaving the fascia open and applying a temporary
abdominal closure device with a vacuum drain.
4. Timing of source control
4.1. Background
Source control is pivotal in themanagement of cIAIs. Drainage of the
infection, thereby controlling the ongoing contamination is considered
crucial to patient outcome. The methods used to obtain source control
Table 2
Source control timing.
Authors ref Type of patients (number) Type of study Main result
Coccolini
et al. [15]
Intraabdominal infections
secondary to complicated
diverticulis (n= 272)
Ancillary assessment from 2
multicenter prospective observational
studies
Increased mortality after 24 h
Karvellas
et al. [16]
cholangitis-associated septic shock
(n= 260)
Retrospectvie, observational Endoscopic biliary decompression N12 h after the onset of shock and delayed
receipt of appropriate anti-microbial therapy both associated with adverse
hospital outcome
Boyer et al.
[19]
Necrotizing soft tissue infections (n
= 106)
Retrospective, observational Time from diagnosis to surgical treatment N14 h in patients with septic shock
independently associated with hospital mortality
Vergidis
et al. [20]
Intraabdominal candidiasis (n=
163)
Retrospective, observational Early interventions (within 5 days of collecting the ﬁrst culture-positive sample
for Candida) associated with survival
Solomkin
et al. [21]
Intraabdominal infection Systematic analysis of literature of
prospective randomized clinical trials
(n= 8)
Deﬁnition of successful source control using percutaneous catheter drainage:
include a reasonable time limit (achieved within 4 days)
Abou-Nukta
et al. [22]
Delaying appendectomy for 12 h Retrospective, observational (n=
309)
Delaying appendectomies for acute appendicitis for 12 to 24 h after presentation:
no signiﬁcant increase the rate of perforations, operative time, or length of stay
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neous drainage). The method selected should be determined by local
capabilities, the presumed source and extent of infection, the surgical
history and patient physiology. The optimal timing of source control re-
mains a controversial topic. The Surviving Sepsis Campaign Guidelines
2016 recommend controlling the source of infection as soon as logisti-
cally and medically practical after diagnosis is made, and no longer
than 6–12 h after diagnosis [44], but it is unclear if earlier intervention
is beneﬁcial. This question is important; access to emergency abdominal
surgery or interventional radiology 24/7 places a signiﬁcant burden on
hospital staff and resources. Of course all available data suffer from the
lack of accurate deﬁnition of adequacy of the initial surgical procedure
to the management of the infection [45].
4.2. Literature review
To date, the data addressing the timing of source control interven-
tion is limited to observational studies, whichmay introduce signiﬁcant
bias to current knowledge. These studies are also confounded by data
from heterogeneous populations (e.g. different sources of sepsis) and
lack of adjustment for other important determinants of outcome (e.g.
adequacy of antibiotic therapy, efﬁcacy of resuscitation). They are also
often limited by focus on speciﬁc types of cIAIs. Furthermore, many
studies use cut-offs (e.g. 6, 12 or 24 h) rather than assessing the time
to source control as a continuous variable.
Despite existing recommendations, current literature shows that
source control is not a priority at times. A Spanish study reported a me-
dian of 4.6 h between the onset of severe sepsis or septic shock and
source control [46] and a German study reported a 2 h median interval
between the diagnosis sepsis and source control [47]. However, a study
from the UK reported that the median times to source control were 18
and 24 h in patients with severe sepsis and septic shock respectively
[48].
Inadequate or delayed or source control is an independent predictor
of poor outcomes and recognizing “failed source control” is often difﬁ-
cult or impossible without abdominal re-exploration [49]. In patients
with diverticulitis, Coccolini et al. found increasedmortality if the initial
intervention was delayed beyond 24 h [50]. In septic shock from biliary
origin, delayed biliary decompression beyond 12 h led to worse out-
come [51]. But does further shortening the interval to surgery provide
any beneﬁt? In patients with peptic ulcer perforation, each hour of
delay between admission and surgery was associated with a 2.4% in-
crease in mortality. In a Japanese study in patients with septic shock
due to gastrointestinal perforation, each hour of delay was associated
with a steep increase in mortality [52]. Bloos et al. found in a large
multicentre study that mortality increased by 1% per each hour of
delay in source control [47]. Earlier smaller-scale data from the same
group did not show this ﬁnding [53].4.3. Recommendations
The current evidence suggests there is no reason to delay source
control even for a few hours in most patients with cIAI. Source control
interventions in these vulnerable patients should be done with care.
The type of intervention and physician expertise should be matched to
the severity of the disease and complexity of the procedure. A careful
evaluation of patient condition and their test results (including imag-
ing) should precede the decision regarding the choice of source control
intervention. The one exception to this rule is infected pancreatic necro-
sis, where a conservative strategy of waiting until the infectious focus is
well-demarcated and amenable to drainage is preferred [54].
4.4. Future research agenda steps
Given the lack of robust information in patients with cIAIs, large
scale observational studies could provide some insight to the impact
of source control timing. RCTs on this topic are challenging to organize
andmay be considered unethical. When evaluating the timing of source
control, adjustment should be made for additional characteristics that
may affect outcome (e.g themethod of source control and its adequacy).
A panel of intensivists, surgeons and interventional radiologists should
ideally review the adequacy of the source control intervention. Studies
should also include information regarding the time of hospital admis-
sion, of diagnosis of cIAI, and of sepsis onset (Table 2).
5. Conclusion
Sepsis is a deadly condition in which the outcome is associated with
prompt and adequate recognition, intensive supportive care, antibiotic
administration and source control. This last itemmakes abdominal sep-
sis a unique treatment challenge. This review summarised the current
approaches and dilemmas regarding ﬁve of the more common chal-
lenges in critically ill patients affected by abdominal sepsis.
COI
No COI to declare regarding the content of this manuscript by any of
the authors.
References
[1] Martin-Loeches I, Valles J, Martin-Loeches I, Millan S, Diaz E, Castanyer E, et al. Public
awareness of sepsis is still poor: we need to do more. Intens Care Med 2017;5:109.
https://doi.org/10.1016/j.medin.2011.10.009.
[2] Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al.
The third international consensus deﬁnitions for Sepsis and septic shock (Sepsis-3).
JAMA 2016;315:801–10. https://doi.org/10.1001/jama.2016.0287.
[3] Kerrigan SW, Martin-Loeches I. Public awareness of sepsis is still poor: we need to
do more. Intensive Care Med 2018. https://doi.org/10.1007/s00134-018-5307-5.
57I. Martin-Loeches et al. / Journal of Critical Care 53 (2019) 53–58[4] Yebenes JC, Ruiz-Rodriguez JCJC, Ferrer R, Cleries M, Bosch A, Lorencio C, et al. Epide-
miology of sepsis in Catalonia: analysis of incidence and outcomes in a European set-
ting. Ann Intensive Care 2017;7:19. https://doi.org/10.1186/s13613-017-0241-1.
[5] Martin-Loeches I, Povoa P, Rodríguez A, Curcio D, Suarez D, J-PJ-P Mira, et al. Inci-
dence and prognosis of ventilator-associated tracheobronchitis (TAVeM): a
multicentre, prospective, observational study. Lancet Respir Med 2015;3:859–68.
https://doi.org/10.1016/S2213-2600(15)00326-4.
[6] Sartelli M, Catena F, Abu-Zidan FM, Ansaloni L, BifﬂWL, Boermeester MA, et al. Man-
agement of intra-abdominal infections: recommendations by the WSES 2016 con-
sensus conference. World J Emerg Surg 2017;12. https://doi.org/10.1186/s13017-
017-0132-7.
[7] Weledji EP, Ngowe MN. The challenge of intra-abdominal sepsis. Int J Surg 2013;11:
290–5. https://doi.org/10.1016/j.ijsu.2013.02.021.
[8] Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, et al. Inﬂammatory responses and
inﬂammation-associated diseases in organs. Oncotarget 2018;9:7204–18. https://
doi.org/10.18632/oncotarget.23208.
[9] Riché F, Gayat E, Collet C, Matéo J, Laisné M-J, Launay J-M, et al. Local and systemic
innate immune response to secondary human peritonitis. Crit Care 2013;17:R201.
https://doi.org/10.1186/cc12895.
[10] O'Leary R-A, Einav S, Leone M, Madách K, Martin C, Martin-Loeches I. Management
of invasive candidiasis and candidaemia in critically ill adults: expert opinion of the
European Society of Anaesthesia Intensive Care Scientiﬁc Subcommittee. J Hosp In-
fect 2018;98. https://doi.org/10.1016/j.jhin.2017.11.020.
[11] Timsit J-F, Azoulay E, Schwebel C, Charles PE, Cornet M, Souweine B, et al. Empirical
Micafungin treatment and survival without invasive fungal infection in adults with
ICU-acquired Sepsis, Candida colonization, and multiple organ failure: the
EMPIRICUS randomized clinical trial. JAMA 2016. https://doi.org/10.1001/jama.
2016.14655.
[12] McHale TM, Garciarena CD, Fagan RP, Smith SGJ, Martin-Loches I, Curley GF, et al. In-
hibition of vascular endothelial cell leak following Escherichia coli attachment in an
experimental model of sepsis. Crit Care Med 2018;46:e805–10. https://doi.org/10.
1097/CCM.0000000000003219.
[13] Garciarena Carolina D, McHale Tony M, Martin-Loeches Ignacio, Kerrigan Steve W.
Pre-emptive and therapeutic value of blocking bacterial attachment to the endothe-
lial alphaVbeta3 integrin with cilengitide in sepsis. Crit Care 2017;21. https://doi.
org/10.1186/s13054-017-1838-3.
[14] Klingensmith NJ, Coopersmith CM. The gut as the motor of multiple organ dysfunc-
tion in critical illness. Crit Care Clin 2016;32:203–12. https://doi.org/10.1016/j.ccc.
2015.11.004.
[15] Coopersmith CM, de Backer D, Deutschman CS, Ferrer R, Lat I, Machado FR, et al. Sur-
viving sepsis campaign: research priorities for sepsis and septic shock. Intensive
Care Med 2018. https://doi.org/10.1007/s00134-018-5175-z.
[16] Farmer D, Tessier JM, Sanders JM, Sawyer RG, Rotstein OD, Dellinger EP, et al. Age
and its impact on outcomes with intra-abdominal infection. Surg Infect (Larchmt)
2017 Feb 1;18:77–82 n.d. https://doi.org/10.1089/sur.2016.184.
[17] Sawyer RG, Claridge JA, Nathens AB, Rotstein OD, Duane TM, Evans HL, et al. Trial of
short-course antimicrobial therapy for intraabdominal infection. N Engl J Med 2015;
372:1996–2005. https://doi.org/10.1056/NEJMoa1411162.
[18] Guilbart M, Zogheib E, Ntouba A, Rebibo L, Régimbeau JM, Mahjoub Y, et al. Compli-
ance with an empirical antimicrobial protocol improves the outcome of complicated
intra-abdominal infections: a prospective observational study. Br J Anaesth 2016;
117:66–72. https://doi.org/10.1093/bja/aew117.
[19] Rattan R, Allen CJ, Sawyer RG, Askari R, Banton KL, Claridge JA, et al. Patients with
complicated intra-abdominal infection presenting with sepsis do not require longer
duration of antimicrobial therapy. J Am Coll Surg 2016;222:440–6. https://doi.org/
10.1016/j.jamcollsurg.2015.12.050.
[20] Sanders JM, Tessier JM, Sawyer R, Dellinger EP, Miller PR, Namias N, et al. Does iso-
lation of Enterococcus affect outcomes in intra-abdominal infections? Surg Infect
(Larchmt) 2017 Nov 1;18:879–85 n.d. https://doi.org/10.1089/sur.2017.121.
[21] Elwood NR, Guidry CA, Duane TM, Cuschieri J, Cook CH, O'Neill PJ, et al. Short-course
antimicrobial therapy does not increase treatment failure rate in patients with intra-
abdominal infection involving fungal organisms. Surg Infect (Larchmt) 2019;19:
376–81. https://doi.org/10.1089/sur.2017.235 n.d.
[22] Montravers P, Tubach F, Lescot T, Veber B, Esposito-Farèse M, Seguin P, et al. Short-
course antibiotic therapy for critically ill patients treated for postoperative intra-
abdominal infection: the DURAPOP randomised clinical trial. Intensive Care Med
2018;44:300–10. https://doi.org/10.1007/s00134-018-5088-x.
[23] Kirkpatrick AW, Roberts DJ, DeWaele J, Jaeschke R, Malbrain MLNG, De Keulenaer B,
et al. Intra-abdominal hypertension and the abdominal compartment syndrome:
updated consensus deﬁnitions and clinical practice guidelines from the world Soci-
ety of the Abdominal Compartment Syndrome. Intensive Care Med 2013;39:
1190–206. https://doi.org/10.1007/s00134-013-2906-z.
[24] Coccolini F, Montori G, Ceresoli M, Catena F, Moore EE, Ivatury R, et al. The role of
open abdomen in non-trauma patient: WSES consensus paper. World J Emerg
Surg 2017;12. https://doi.org/10.1186/s13017-017-0146-1.
[25] Sartelli M, Catena F, Di Saverio S, Ansaloni L, Malangoni M, Moore EE, et al. Current
concept of abdominal sepsis: WSES position paper. World J Emerg Surg 2014;9:22.
https://doi.org/10.1186/1749-7922-9-22.
[26] Demetriades D, Salim A. Management of the open abdomen. Surg Clin North Am
2014;94:131–53. https://doi.org/10.1016/j.suc.2013.10.010.
[27] Chen Y, Ye J, Song W, Chen J, Yuan Y, Ren J. Comparison of outcomes between early
Fascial closure and delayed abdominal closure in patients with open abdomen: a
systematic review and meta-analysis. Gastroenterol Res Pract 2014;2014:784056.
https://doi.org/10.1155/2014/784056.
[28] Fortelny RH, Hofmann A, Gruber-Blum S, Petter-Puchner AH, Glaser KS. Delayed clo-
sure of open abdomen in septic patients is facilitated by combined negative pressurewound therapy and dynamic fascial suture. Surg Endosc 2014;28:735–40. https://
doi.org/10.1007/s00464-013-3251-6.
[29] Godat L, Kobayashi L, Costantini T, Coimbra R. Abdominal damage control surgery
and reconstruction: world society of emergency surgery position paper. World J
Emerg Surg 2013;8:53. https://doi.org/10.1186/1749-7922-8-53.
[30] Hamosh M, Bitman J, Liao TH, Mehta NR, Buczek RJ, Wood DL, et al. Gastric lipolysis
and fat absorption in preterm infants: effect of medium-chain triglyceride or long-
chain triglyceride-containing formulas. Pediatrics 1989;83:86–92.
[31] Glass GE, Murphy GRF, Nanchahal J. Does negative-pressure wound therapy inﬂu-
ence subjacent bacterial growth? A systematic review. J Plast Reconstr Aesthet
Surg 2017;70:1028–37. https://doi.org/10.1016/j.bjps.2017.05.027.
[32] Acosta S, Björck M, Petersson U. Vacuum-assisted wound closure and mesh-
mediated fascial traction for open abdomen therapy - a systematic review.
Anaesthesiol Intensive Ther 2017;49:139–45. https://doi.org/10.5603/AIT.a2017.
0023.
[33] Rausei S, Amico F, Frattini F, Rovera F, Boni L, Dionigi G. A review on vacuum-assisted
closure therapy for septic peritonitis open abdomen management. Surg Technol Int
2014;25:68–72.
[34] MalbrainMLNG, Van Regenmortel N, Saugel B, De Tavernier B, Van Gaal P-J, Joannes-
Boyau O, et al. Principles of ﬂuid management and stewardship in septic shock: it is
time to consider the four D's and the four phases of ﬂuid therapy. Ann Intensive Care
2018;8:66. https://doi.org/10.1186/s13613-018-0402-x.
[35] Malbrain MLNG, De laet I. It's all in the gut: introducing the concept of acute bowel
injury and acute intestinal distress syndrome. Crit CareMed 2009;37:365–6. https://
doi.org/10.1097/CCM.0b013e3181935001.
[36] Kubiak BD, Albert SP, Gatto LA, Snyder KP, Maier KG, Vieau CJ, et al. Peritoneal neg-
ative pressure therapy prevents multiple organ injury in a chronic porcine sepsis
and ischemia/reperfusion model. Shock 2010;34:525–34. https://doi.org/10.1097/
SHK.0b013e3181e14cd2.
[37] Powell NJ, Collier B. Nutrition and the open abdomen. Nutr Clin Pract 2012;27:
499–506. https://doi.org/10.1177/0884533612450918.
[38] CheathamML, Safcsak K, Brzezinski SJ, LubeMW. Nitrogen balance, protein loss, and
the open abdomen. Crit CareMed 2007;35:127–31. https://doi.org/10.1097/01.CCM.
0000250390.49380.94.
[39] Huang Q, Li J, Lau W-Y. Techniques for abdominal wall closure after damage control
laparotomy: from temporary abdominal closure to early/delayed fascial closure-a
review. Gastroenterol Res Pract 2016;2016:2073260. https://doi.org/10.1155/2016/
2073260.
[40] De Laet IE, Ravyts M, Vidts W, Valk J, De Waele JJ, Malbrain MLNG. Current insights
in intra-abdominal hypertension and abdominal compartment syndrome: open the
abdomen and keep it open! Langenbecks Arch Surg 2008;393:833–47. https://doi.
org/10.1007/s00423-008-0347-x.
[41] De Waele JJ, Kaplan M, Sugrue M, Sibaja P, Björck M. How to deal with an open ab-
domen? Anaesthesiol Intensive Ther 2015;47:372–8. https://doi.org/10.5603/AIT.
a2015.0023.
[42] Robledo FA, Luque-de-León E, Suárez R, Sánchez P, De-la-Fuente M, Vargas A, et al.
Open versus closed management of the abdomen in the surgical treatment of severe
secondary peritonitis: a randomized clinical trial. Surg Infect (Larchmt) 2007;8:
63–72. https://doi.org/10.1089/sur.2006.8.016.
[43] Kirkpatrick AW, Coccolini F, Ansaloni L, Roberts DJ, Tolonen M, McKee JL, et al.
Closed or open after source control laparotomy for severe complicated intra-
abdominal sepsis (the COOL trial): study protocol for a randomized controlled
trial. World J Emerg Surg 2018;13:26. https://doi.org/10.1186/s13017-018-
0183-4.
[44] Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving
sepsis campaign: international guidelines for management of sepsis and septic
shock: 2016. Intensive Care Med 2017;43:304–77. https://doi.org/10.1007/s00134-
017-4683-6.
[45] Solomkin JS, Ristagno RL, Das AF, Cone JB, Wilson SE, Rotstein OD, et al. Source
control review in clinical trials of anti-infective agents in complicated intra-
abdominal infections. Clin Infect Dis 2013;56:1765–73. https://doi.org/10.
1093/cid/cit128.
[46] Martínez ML, Ferrer R, Torrents E, Guillamat-Prats R, Gomà G, Suárez D, et al. Impact
of source control in patients with severe sepsis and septic shock. Crit Care Med
2017;45. https://doi.org/10.1097/CCM.0000000000002011.
[47] Bloos F, Rüddel H, Thomas-Rüddel D, Schwarzkopf D, Pausch C, Harbarth S, et al. Ef-
fect of a multifaceted educational intervention for anti-infectiousmeasures on sepsis
mortality: a cluster randomized trial. Intensive Care Med 2017;43:1602–12. https://
doi.org/10.1007/s00134-017-4782-4.
[48] UK National Surgical Research Collaborative. Multicentre observational study of ad-
herence to sepsis six guidelines in emergency general surgery. Br J Surg 2017;104:
e165–71. https://doi.org/10.1002/bjs.10432.
[49] Tolonen M, Coccolini F, Ansaloni L, Sartelli M, Roberts DJ, McKee JL, et al. Getting the
invite list right: a discussion of sepsis severity scoring systems in severe complicated
intra-abdominal sepsis and randomized trial inclusion criteria. World J Emerg Surg
2018;13:17. https://doi.org/10.1186/s13017-018-0177-2.
[50] Coccolini F, Trevisan M, Montori G, Sartelli M, Catena F, Ceresoli M, et al. Mortality
rate and antibiotic resistance in complicated diverticulitis: report of 272 consecutive
patients worldwide: a prospective cohort study. Surg Infect (Larchmt) 2017. https://
doi.org/10.1089/sur.2016.283.
[51] Karvellas CJ, Abraldes JG, Zepeda-Gomez S, Moffat DC, Mirzanejad Y, Vazquez-
Grande G, et al. The impact of delayed biliary decompression and anti-microbial
therapy in 260 patients with cholangitis-associated septic shock. Aliment Pharmacol
Ther 2016;44:755–66. https://doi.org/10.1111/apt.13764.
[52] Azuhata T, Kinoshita K, Kawano D, Komatsu T, Sakurai A, Chiba Y, et al. Time from
admission to initiation of surgery for source control is a critical determinant of
58 I. Martin-Loeches et al. / Journal of Critical Care 53 (2019) 53–58survival in patients with gastrointestinal perforation with associated septic shock.
Crit Care 2014;18:R87. https://doi.org/10.1186/cc13854.
[53] Bloos F, Thomas-Rüddel D, Rüddel H, Engel C, Schwarzkopf D, Marshall JC, et al. Im-
pact of compliance with infection management guidelines on outcome in patients
with severe sepsis: a prospective observational multi-center study. Crit Care 2014;
18:R42. https://doi.org/10.1186/cc13755.[54] Al-Sarireh B, Mowbray NG, Al-Sarira A, Grifﬁth D, Brown TH, Wells T. Can infected
pancreatic necrosis really be managed conservatively? Eur J Gastroenterol Hepatol
2018;30:1327–31. https://doi.org/10.1097/MEG.0000000000001231.
